On the in vivo early toxic properties of Aβ25-35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression

Amyloid-beta peptide (A beta) deposition is assumed to play a pathogenic role in the brain of Alzheimer's disease patients. To date, the precise mechanisms underlying A beta toxicity are not fully understood. A recent hypothesis suggesting that the Receptor-for-Advanced-Glycation-End-Products (RAGE)-a trans-membrane protein signaling for oxidative stress-is involved in A beta toxicity is gaining attention. Early A beta toxicity could indeed help to explain the deleterious events further produced by this molecule in the brain. In this work, we evaluated the pattern of early expression of RAGE in the toxic model induced by A beta(25-35) in rat CA1 region. Intrahippocampal injections of A beta(25-35) in rats increased the RAGE expression at 24 h post-injection; this event was accompanied by increased components of RAGE downstream signaling in hippocampal cells, such as enhanced expression of the pro-apoptotic factor NF-kappa B, increased nitric oxide production. LDH leakage, mitochondrial dysfunction, increased TNF-alpha expression, antioxidant genes down-regulation, and augmented neurodegeneration. Our findings support an active role of RAGE during the early stages of A beta(25-35) toxicity in the hippocampus. (C) 2010 Elsevier Inc. All rights reserved.